ARCHIVES

ODAC Recommends Approval Of Nplate For Thrombocytopenia.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

MacFarlane, Frelick to Speak At Seminar

July 22, 1983

In Brief: Fischinger, SAIC Win $400 Million Contract

March 3, 1995

Women’s Health: Treatment to Move Toward Pre-Cancer, Klausner Says

December 5, 1997

Funding Opportunity: Stand Up To Cancer Canada to Fund Two Dream Teams

October 17, 2014

“With resources now constrained, the ability of NCI to be responsive to its constituencies has been compromised.”

July 7, 1995